
Edwards Lifesciences Corporation EW
$ 81.39
-1.83%
Annual report 2025
added 02-25-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
585 M |
Market Cap[1] |
$ 47.6 B |
EBITDA (LTM) |
$ 1.75 B |
P/E (LTM) |
12.16 |
P/S (LTM) |
8.28 |
EPS (LTM) |
6.82 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Alphatec Holdings
ATEC
|
$ 7.01 | -31.48 % | $ 1.05 B | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.55 | 2.9 % | $ 133 M | Nasdaq Global Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 10.96 | -1.26 % | $ 310 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | 0.93 % | $ 38 M | Nasdaq Capital Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.18 | 0.93 % | $ 1.33 M | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 11.58 | 0.43 % | $ 415 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.06 | 0.48 % | $ 18 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Electromed
ELMD
|
$ 25.81 | -0.5 % | $ 218 M | NYSE American | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 16.89 | -0.88 % | $ 396 M | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 4.64 | -3.63 % | $ 982 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
LivaNova PLC
LIVN
|
$ 64.24 | 11.54 % | $ 3.5 B | Nasdaq Global Select Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Myomo
MYO
|
$ 0.86 | -2.36 % | $ 36 M | NYSE American | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Orthofix Medical
OFIX
|
$ 12.46 | 0.12 % | $ 493 M | Nasdaq Global Select Market,SPB | ||
|
Globus Medical
GMED
|
$ 89.39 | -0.71 % | $ 12.1 B | NYSE,SPB | ||
|
Insulet Corporation
PODD
|
$ 154.57 | -7.74 % | $ 10.9 B | Nasdaq Global Select Market,SPB | ||
|
CONMED Corporation
CNMD
|
$ 37.07 | 1.17 % | $ 1.15 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 46.14 | -4.37 % | $ 1.36 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.57 | 6.2 % | $ 7.13 M | Nasdaq Capital Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 86.52 | 0.75 % | $ 3.01 B | NYSE,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Stryker Corporation
SYK
|
$ 292.66 | -0.88 % | $ 112 B | NYSE,SPB | ||
|
Tactile Systems Technology
TCMD
|
$ 23.76 | -1.21 % | $ 543 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.55 | 1.28 % | $ 66.4 M | Nasdaq Capital Market | ||
|
TransMedics Group
TMDX
|
$ 77.06 | -18.82 % | $ 2.62 B | Nasdaq Global Market | ||
|
Tandem Diabetes Care
TNDM
|
$ 18.2 | -6.28 % | $ 1.24 B | Nasdaq Global Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.